TG Therapeutics
TGTX
TGTX
238 hedge funds and large institutions have $1.38B invested in TG Therapeutics in 2024 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 78 increasing their positions, 75 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
2.28% less ownership
Funds ownership: 60.68% → 58.4% (-2.3%)
12% less capital invested
Capital invested by funds: $1.57B → $1.38B (-$190M)
Holders
238
Holding in Top 10
5
Calls
$55.2M
Puts
$38.6M
Top Buyers
| 1 | +$38.3M | |
| 2 | +$30.2M | |
| 3 | +$24.6M | |
| 4 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
+$22.4M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$21.5M |
Top Sellers
| 1 | -$69.1M | |
| 2 | -$37.1M | |
| 3 | -$27.5M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$17.4M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.2M |